Search for a report

EUROPE IN-VITRO FERTILIZATION MARKET FORECAST 2018-2026

  • You are here:
  • Home
  • Downloads
  • EUROPE IN-VITRO FERTILIZATION MARKET FORECAST 2018-2026

EUROPE IN-VITRO FERTILIZATION MARKET FORECAST 2018-2026

The Europe in-vitro fertilization market is a pioneer in the global In-vitro fertilization scene. The region is presently ruling the global market as it captured the highest revenue share in 2017.  the European market is expected to further evolve at 9.03% CAGR, raising a net total of $ xx million. U.K, Spain, Germany, France and rest of Europe are the markets analyzed for this region.

EUROPE IN-VITRO FERTILIZATION MARKET FORECAST 2018-2026

Europe In-vitro Fertilization Market by Product (Reagents, Equipment) by Procedure (ICSI, PGD, FET/FER) by End-user (Fertility and Surgical Centers, Hospitals and Research Laboratories, Cryobanks) by Geography

Request free sample

The Europe in-vitro fertilization market is a pioneer in the global In-vitro fertilization scene. The region is presently ruling the global market as it captured the highest revenue share in 2017. Over the forecast period of 2018-2026, the European market is expected to further evolve at 9.03% CAGR.

U.K, Spain, Germany, France, Italy and the rest of Europe are the markets analyzed for this region. The European region is held in high regards in the Global IVF market as it was the first region to come up with the in-vitro fertilization procedure. Also, Europe was one of the torchbearers for legalizing three-parent IVF or the mitochondrial transfer technique. The Spain market is forecasted to race ahead with the highest CAGR by the end of 2026. However, revenue-wise, the United Kingdom IVF market is expected to rule this region.

Some notable players in this market are Thermo Fisher Scientific Inc, Copper Surgical Inc, The Baker Company Inc, Auxogyn, Ferring Pharmaceuticals, Merck Serono Cook Medical Inc, Vitrolife Ab, Genea, Andrology Solutions, Halotech DNA, Esco Micro Pte. Ltd, Ovascience, Irvine Scientific (Subsidiary of Nippon Mining Holdings), and Ivftech Aps.

 

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


    1. RESEARCH SCOPE
      • STUDY GOALS
      • SCOPE OF THE MARKET STUDY
      • WHO WILL FIND THIS REPORT USEFUL?
      • STUDY AND FORECASTING YEARS
    2. RESEARCH METHODOLOGY
      • SOURCES OF DATA
        • SECONDARY DATA
        • PRIMARY DATA
      • TOP DOWN APPROACH
      • BOTTOM-UP APPROACH
      • DATA TRIANGULATION
      • RESEARCH METHODOLOGY
    3. EXECUTIVE SUMMARY
      • MARKET SUMMARY
      • KEY FINDINGS
        • EUROPE DOMINATES THE EUROPE IVF MARKET
        • INSURANCE COVERAGE FOR IVF
        • GROWTH OF MEDICAL TOURISM
    1. MARKET DYNAMICS
      • MARKET DEFINITION
      • DRIVERS
        • INCREASING RATE OF INFERTILITY ACROSS THE GLOBE
        • FLEXIBLE GOVERNMENT REGULATIONS FOR FERTILITY TOURISM
        • IMPROVED SURROGACY LAWS
        • HIGH SUCCESS RATES OF ADVANCED IN-VITRO FERTILIZATION TREATMENTS
      • RESTRAINTS
        • HIGH COST
        • COUNTRY WISE REGULATORY ISSUES
      • OPPORTUNITIES
        • INCREASING DEMAND FOR LOW-COST PROCEDURES
        • IVF ATTRACTING INVESTMENTS FROM PRIVATE EQUITY INVESTORS
      • CHALLENGES
        • INFERTILITY CONSIDERED A SOCIAL TABOO AMONGST MEN
        • TRADITIONAL TREATMENTS USED WIDELY AS AN ALTERNATIVE TO IVF
          • DIET AND SUPPLEMENTS
          • ACUPUNCTURE
          • THERAPY
          • QIGONG
    1. MARKET BY PRODUCT AND PROCEDURES
      • BY PRODUCT
        • REAGENTS
        • EQUIPMENTS
      • BY PROCEDURE
        • INTRA CYTOPLASMIC SPERM INJECTION (ICSI)
        • PRE IMPLANTATION GENETIC DIAGNOSIS (PGD)
        • FROZEN EMBRYO TRANSFER/REPLACEMENT (FET/FER)
        • OTHERS
    1. MARKET BY END-USER
      • FERTILITY AND SURGICAL CENTERS
      • HOSPITALS AND RESEARCH LABORATORIES
      • CRYOBANKS
    2. KEY ANALYTICS
      • PORTERS 5 FORCE MODEL
        • THREAT OF NEW ENTRANTS
        • THREAT OF SUBSTITUTE PRODUCTS
        • BARGAINING POWER OF BUYERS
        • BARGAINING POWER OF SUPPLIERS
        • INTENSITY OF COMPETITIVE RIVALRY
      • VALUE CHAIN ANALYSIS
        • RAW MATERIAL PROCUREMENT
        • MANUFACTURING
        • SUPPLY LOGISTICS
        • DISTRIBUTION CHANNELS
        • END USERS
      • KEY BUYING CRITERIA
        • TREATMENT OPTIONS
        • QUALITY OF MEDICAL PROCEDURES
        • PRICE OF TREATMENTS
        • SHIFT TOWARDS MEDICAL TOURISM
        • REIMBURSEMENT
      • REGULATORY FRAMEWORK
      • INVESTMENT OUTLOOK
        • END-USER OUTLOOK
      • VENDOR LANDSCAPE
      • OPPORTUNITY MATRIX
    3. GEOGRAPHICAL ANALYSIS
      • UNITED KINGDOM
      • FRANCE
      • GERMANY
      • SPAIN
      • ITALY
      • REST OF EUROPE
    4. COMPETITIVE LANDSCAPE
      • MARKET SHARE ANALYSIS
        • VITROLIFE
        • COOPER SURGICAL
        • MERCK
        • COOK MEDICAL
        • FERRING PHARMACEUTICALS
      • TOP WINNING STRATEGIES
      • COMPANY PROFILES
        • ANDROLOGY SOLUTIONS
          • OVERVIEW
          • PRODUCT PORTFOLIO
          • SCOT ANALYSIS
          • STRATEGIC ANALYSIS
        • AUXOGYN
          • OVERVIEW
          • PRODUCTS
          • STRATEGIC INITIATIVES
          • SCOT ANALYSIS
          • STRATEGIC ANALYSIS
        • COOK MEDICAL INC
          • OVERVIEW
          • PRODUCT PORTFOLIO
          • STRATEGIC INITIATIVES
          • SCOT ANALY
          • STRATEGIC ANALYSIS
        • COPPER SURGICAL INC
          • OVERVIEW
          • PRODUCT PORTFOLIO
          • STRATEGIC INITIATIVES
          • SCOT ANALYSIS
          • STRATEGIC ANALYSIS
        • ESCO MICRO PTE. LTD.
          • OVERVIEW
          • PRODUCT PORTFOLIO
          • STRATEGIC INITIATIVES
          • SCOT ANALYSIS
          • STRATEGIC ANALYSIS
        • FERRING PHARMACEUTICALS
          • OVERVIEW
          • PRODUCT PORTFOLIO
          • STRATEGIC INITIATIVES
          • SCOT ANALYSIS
          • STRATEGIC ANALYSIS
        • GENEA
          • OVERVIEW
          • PRODUCT PORTFOLIO
          • STRATEGIC INITIATIVES
          • SCOT ANALYSIS
          • STRATEGIC ANALYSIS
        • HALOTECH DNA
          • OVERVIEW
          • PRODUCT PORTFOLIO
          • SCOT ANALYSIS
          • STRATEGIC ANALYSIS
        • IRVINE SCIENTIFIC (SUBSIDIARY OF NIPPON MINING HOLDINGS)
          • OVERVIEW
          • PRODUCT PORTFOLIO
          • STRATEGIC INITIATIVES
          • SCOT ANALYSIS
          • STRATEGIC ANALYSIS
        • IVFTECH APS
          • OVERVIEW
          • PRODUCT PORTFOLIO
          • SCOT ANALYSIS
          • STRATEGIC ANALYSIS
        • MERCK SERONO
          • OVERVIEW
          • PRODUCT PORTFOLIO
          • STRATEGIC INITIATIVES
          • SCOT ANALYSIS
          • STRATEGIC ANALYSIS
        • OVASCIENCE
          • OVERVIEW
          • PRODUCT PORTFOLIO
          • STRATEGIC INITIATIVES
          • SCOT ANALYSIS
          • STRATEGIC ANALYSIS
        • THE BAKER COMPANY, INC.
          • OVERVIEW
          • PRODUCT PORTFOLIO
          • SCOT ANALYSIS
          • STRATEGIC ANALYSIS
        • THERMO FISHER SCIENTIFIC INC
          • OVERVIEW
          • PRODUCT PORTFOLIO
          • STRATEGIC INITIATIVE
          • SCOT ANALYSIS
          • STRATEGIC ANALYSIS
        • VITROLIFE AB
          • OVERVIEW
          • PRODUCT PORTFOLIO
          • STRATEGIC INITIATIVES
          • SCOT ANALYSIS
          • STRATEGIC ANALYSIS

    LIST OF TABLES

    TABLE 1 EUROPE IN-VITRO FERTILIZATION MARKET BY COUNTRY 2018-2026 ($ MILLION)

    TABLE 2 EUROPE IVF MARKET BY PRODUCT AND PROCEDURES 2018-2026 ($ MILLION)

    TABLE 3 EUROPE IVF MARKET BY PRODUCTS 2018-2026 ($ MILLION)

    TABLE 4 EUROPE IVF MARKET BY PROCEDURE 2018-2026 ($ MILLION)

    TABLE 5 EUROPE IVF MARKET BY END-USER 2018-2026 ($ MILLION)

    TABLE 6 EUROPE IVF MARKET BY COUNTRY 2018-2026 ($ MILLION)

     

    LIST OF FIGURES

    FIGURE 1 EUROPE IN-VITRO FERTILIZATION MARKET BY PROCEDURE 2018-2026 ($ MILLION)

    FIGURE 2 EUROPE IVF MARKET 2018-2026 ($ MILLION)

    FIGURE 3 EVOLUTION OF IVF MARKET

    FIGURE 4 EUROPE REAGENTS MARKET 2018-2026 ($ MILLION)

    FIGURE 5 EUROPE EQUIPMENTS MARKET 2018-2026 ($ MILLION)

    FIGURE 6 EUROPE INTRA CYTOPLASMIC SPERM INJECTION (ICSI) MARKET 2018-2026 ($ MILLION)

    FIGURE 7 EUROPE PRE-IMPLANTATION GENETIC DIAGNOSIS (PGD) MARKET 2018-2026 ($ MILLION)

    FIGURE 8 EUROPE FROZEN EMBRYO TRANSFER/REPLACEMENT (FET/FER) MARKET 2018-2026 ($ MILLION)

    FIGURE 9 EUROPE OTHERS MARKET 2018-2026 ($ MILLION)

    FIGURE 10 EUROPE FERTILITY AND SURGICAL CENTERS MARKET 2018-2026 ($ MILLION)

    FIGURE 11 EUROPE HOSPITALS AND RESEARCH LABORATORIES MARKET 2018-2026 ($ MILLION)

    FIGURE 12 EUROPE CRYOBANKS MARKET 2018-2026 ($ MILLION)

    FIGURE 13 INVESTMENT PROPOSITION FOR EUROPE IVF MARKET BY END-USER – 2017

    FIGURE 14 UNITED KINGDOM IVF MARKET 2018-2026 ($ MILLION)

    FIGURE 15 FRANCE IVF MARKET 2018-2026 ($ MILLION)

    FIGURE 16 GERMANY IVF MARKET 2018-2026($MILLION)

    FIGURE 17 SPAIN IVF MARKET 2018-2026 ($ MILLION)

    FIGURE 18 ITALY IVF MARKET 2018-2026 ($ MILLION)

    FIGURE 19 REST OF EUROPE IVF MARKET 2018-2026 ($ MILLION)

    FIGURE 20 EUROPE IVF MARKET SHARE OF MAJOR COMPANIES – 2017

     

    1. GEOGRAPHICAL ANALYSIS
      • UNITED KINGDOM
      • FRANCE
      • GERMANY
      • SPAIN
      • ITALY
      • REST OF EUROPE
    2. MARKET BY PRODUCT AND PROCEDURES
      • BY PRODUCT
        • REAGENTS
        • EQUIPMENTS
      • BY PROCEDURE
        • INTRA CYTOPLASMIC SPERM INJECTION (ICSI)
        • PRE IMPLANTATION GENETIC DIAGNOSIS (PGD)
        • FROZEN EMBRYO TRANSFER/REPLACEMENT (FET/FER)
        • OTHERS
    1. MARKET BY END-USER
      • FERTILITY AND SURGICAL CENTERS
      • HOSPITALS AND RESEARCH LABORATORIES
      • CRYOBANKS

     

    To request a free sample copy of this report, please complete the form below :
    We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


      Choose License Type

      Buy Now